AAKAAR — Aakaar Medical Technologies Income Statement
0.000.00%
Last trade - 00:00- IN₹1.01bn
- IN₹1.03bn
- IN₹669.64m
Annual income statement for Aakaar Medical Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 195 | 328 | 461 | 616 | 670 |
| Cost of Revenue | |||||
| Gross Profit | 104 | 178 | 252 | 354 | 388 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 171 | 293 | 412 | 520 | 568 |
| Operating Profit | 23.7 | 34.4 | 48.6 | 96.1 | 102 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 22 | 31 | 38.9 | 80.8 | 91.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 16.2 | 21.5 | 28.7 | 60.4 | 66.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 16.2 | 21.5 | 28.7 | 60.4 | 66.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 16.2 | 21.5 | 28.7 | 60.4 | 66.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.14 | 1.52 | 2.03 | 4.26 | 4.99 |